Skip to main content

Table 3 Correlation between the 5-year disease-specific survival rate and clinicopathological features in oral squamous cell carcinoma (OSCC)

From: Clinical significance of erythropoietin receptor expression in oral squamous cell carcinoma

Variables

Number of patients

5-Year disease-specific survival rate (%)

p-Value

Gender

Male

239

64.8

0.174

Female

17

81.9

 

EPOR

Low expression

146

73.5

0.0017*

High expression

110

55.9

 

Age, years

<60

202

67.9

0.142

≥60

54

58.6

 

T classification

T1, T2

94

81.9

<0.001*

T3, T4

162

56.6

 

N classification

Negative

153

79.4

<0.001*

Positive

103

45.8

 

TNM stage

I, II

66

90.9

<0.001*

III, IV

190

57.2

 
  1. EPOR: erythropoietin receptor; *statistically significant (p < 0.05).